Literature DB >> 12669085

Management of degenerative changes and stenosis of the lumbar spinal canal secondary to cervical spinal cord injury.

R Abel1, H A Cerrel Bazo, P J Kluger, F Selmi, T Meiners, A Vaccaro, J Ditunno, H J Gerner.   

Abstract

We describe the case of a 47-year-old female who sustained a C5/6 fracture with C6 complete spinal cord injury 26 years ago. She presented with increased spasticity of the lower extremities, the abdominal wall and episodes of autonomic dysreflexia. Imaging of the spine revealed post-traumatic kyphosis at the level of the injury and degenerative changes of the lumbar spine with marked facet joint hypertrophy at the level of L4/5 causing severe spinal canal stenosis. Discussants of this case comment on the possible pathophysiological mechanisms causing autonomic dysreflexia, especially the development of degenerative changes, Charcot arthropathy and the role of tethering mechanisms. The diagnostic options and management approaches are also discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12669085     DOI: 10.1038/sj.sc.3101435

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  3 in total

1.  Case series on the Charcot neuroarthropathy in hands after cervical central cord syndrome.

Authors:  Wenting Wang; Anni Tong; Nan Liu; Fin Biering-Soerensen; Shuai Tong
Journal:  BMC Musculoskelet Disord       Date:  2022-06-06       Impact factor: 2.562

2.  The change tendency of PI3K/Akt pathway after spinal cord injury.

Authors:  Peixun Zhang; Luping Zhang; Lei Zhu; Fangmin Chen; Shuai Zhou; Ting Tian; Yuqiang Zhang; Xiaorui Jiang; Xuekun Li; Chuansen Zhang; Lin Xu; Fei Huang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

3.  Leg sympathetic response to noxious skin stimuli is similar in high and low level human spinal cord injury.

Authors:  M Kevin Garrison; Alexander V Ng; Brian D Schmit
Journal:  Clin Neurophysiol       Date:  2007-12-04       Impact factor: 3.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.